Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the ...

Struggling with osteoarthritis pain? Discover how Low-dose radiation therapy (LD-RT) offers a non-invasive, side-effect-free ...

Some individuals who have had anterior-cruciate-ligament reconstruction (ACLR), the kind of surgery often performed on ...

Patients with osteoarthritis, but not immune-related arthritis, demonstrate increased odds for developing overactive bladder ...

A recent research which used NHANES data from 2015 to 2018 discovered a strong correlation between the risk of osteoarthritis ...

Some individuals who have had anterior-cruciate-ligament reconstruction (ACLR), the kind of surgery often performed on ...

A dietary fiber intake between 14.4 and 26.7 g reduced the risk of osteoarthritis, but an intake above this dose was not ...

Enlivex recently reported positive interim six (6) months efficacy data from the first stage of its ongoing randomized, multi-country Phase I/II Allocetra™ trial in patients with moderate to severe ...

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.

Enlivex to receive Chinese patent for use of Allocetra as a potential treatment in patients with osteoarthritis: Nes-Ziona, Israel Wednesday, March 19, 2025, 10:00 Hrs [IST] Enliv ...